Annual Report 2022
Research Institute
- Research Institute
- Index
- Preface
- Organization
- Activities of the Divisions
- Division of Molecular Pathology
- Division of Cellular Signaling
- Division of Cancer Biology
- Division of Cancer Evolution
- Division of Cancer RNA Research
- Division of Hematological Malignancy
- Division of Cancer Stem Cell
- Division of Cancer Genomics
- Division of Genome Biology
- Division of Brain Tumor Translational Research
- Division of Molecular Oncology
- Division of Genome Analysis Platform Development
- Division of Bioinformatics
- Division of Cancer Pathophysiology
- Division of Cancer Therapeutics
- Division of Molecular Pharmacology / Department of Pharmacology and Therapeutics
- Division of Rare Cancer Research
- Division of Cancer Immunology
- Division of Medical Ai Research and Development
- Laboratory of Molecular Carcinogenesis
- Laboratory of Fundamental Oncology
- Laboratory of Molecular Genetics
- Laboratory of Genome Stability Maintenance
- Laboratory of Cancer Cell Systems
- Laboratory of Genome Stress Signaling
- Laboratory of Integrative Oncology
- Laboratory of Intracellular Traffic and Oncology
- Central Animal Division
- Central Radioisotope Division
- Department of Biobank and Tissue Resources
- Department of Clinical Genomics
- Department of Translational Oncology
- Department of Cancer Model Development
- Department of Analytical Pathology
- Department of Immune Medicine